Basics Aquestive Therapeutics, Inc. IPO Date: July 23, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $851.65M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.72% Avg Daily Range (30 D): $0.17 | 2.80% Avg Daily Range (90 D): $0.14 | 2.99% Institutional Daily Volume Avg Daily Volume: .77M Avg Daily Volume (30 D): 3.4M Avg Daily Volume (90 D): 2.15M Trade Size Avg Trade Size (Sh.): 176 Avg Trade Size (Sh.) (30 D): 158 Avg Trade Size (Sh.) (90 D): 158 Institutional Trades Total Inst.Trades: 169 Avg Inst. Trade: $1.74M Avg Inst. Trade (30 D): $1.22M Avg Inst. Trade (90 D): $1.18M Avg Inst. Trade Volume: .43M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.87M Avg Closing Trade (30 D): $1.28M Avg Closing Trade (90 D): $1.24M Avg Closing Volume: 419.79K     News Oct 8, 2025 @ 11:00 AM Aquestive Therapeutics Broadens Patent Estate for ... Source: Aquestive Therapeutics Sep 4, 2025 @ 11:00 AM Aquestive Therapeutics Announces that FDA Will Not... Source: Aquestive Therapeutics Aug 14, 2025 @ 10:00 AM Aquestive Therapeutics Announces $75M Strategic Fu... Source: Aquestive Therapeutics Jul 22, 2025 @ 11:00 AM Aquestive Therapeutics Names Sherry Korczynski as ... Source: Aquestive Therapeutics Apr 9, 2025 @ 11:00 AM Aquestive Therapeutics to Participate in Piper San... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.14 $-.24 $-.19 Diluted EPS $-.14 $-.24 $-.19 Revenue $ 10M $ 8.72M $ 11.87M Gross Profit $ 5.44M $ 5.07M $ 7.35M Net Income / Loss $ -13.55M $ -22.93M $ -17.06M Operating Income / Loss $ -11.37M $ -19.37M $ -13.58M Cost of Revenue $ 4.56M $ 3.65M $ 4.52M Net Cash Flow $ -8.12M $ -2.89M $ -6.35M PE Ratio